Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study

BACKGROUND: Multi-drug resistant Tuberculosis (MDR-TB) is a strain of Mycobacterium tuberculosis that is resistant to at least Rifampicin and Isoniazid drugs. The treatment success rate for MDR-TB cases is lower than for drug susceptible TB. Globally only 55% of MDR-TB patients were successfully tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Molie, Teklu, Teklemariam, Zelalem, Klinkenberg, Eveline, Dessie, Yadeta, Kumsa, Andargachew, Mohammed, Hussen, Debebe, Adisalem, Assefa, Dawit, Habte, Abebe, Bedru, Ahmed, Fiseha, Daniel, Seyoum, Berhanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751790/
https://www.ncbi.nlm.nih.gov/pubmed/31533644
http://dx.doi.org/10.1186/s12879-019-4411-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751790/
https://www.ncbi.nlm.nih.gov/pubmed/31533644
http://dx.doi.org/10.1186/s12879-019-4411-7

Ejemplares similares